The company said Thursday it’s implementing “a two-pronged variant strategy” for the variant.
{iframe}https://www.bizjournals.com/washington/news/2021/12/02/novavax-covid-vaccine-omicron-variant-expansion.html{/iframe}
Novavax tailoring Covid-19 vaccine to Omicron variant while advancing campus expansion plans – Washington Business Journal
The company said Thursday it’s implementing “a two-pronged variant strategy” for the variant.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.